The American pharmaceutical company Verseon is attached to the distributed ledger technology. Its subsidiary, BlockRules, is launching a blockchain based platform to support, sell, launch, and trade securities.
The creators of the project believe that the platform will provide fully regulated, safe and transparent support for all securities transactions, including decentralized trade. According to the company's representatives, the exchange will help other pharmaceutical corporations to reconsider their strategy of financial development.
The project aims to change the way that new medicines and innovations in the health sector are financed through more democratic access to investment. The launch of the exchange is also one more step towards meeting the new technologies in the field of medicine.
WHY IS IT IMPORTANT?
- The main product of Verseon is a patented physical platform for finding medicines. The company was founded in 2002 and is currently listed on the London Stock Exchange with a market capitalization of $277 million (approximately 211 million euro).
- Pharmaceutical companies are increasingly beginning to appreciate the benefits of distributed ledger technology. The industry usually uses blockchain for storing and protecting data on the supply of medicines, which helps to avoid falsification and guarantee the quality of the goods.